Jump to content

4D Pharma finds success for its Parkinson’s treatment


Recommended Posts

The US Federal Drug Administration has given clearance for 4D Pharma (DDDD) to move its treatment for Parkinson’s disease into trials. CEO, Duncan Peyton, joins IGTV’s Jeremy Naylor to explain what this means, what is next and the time it could now take to clear the next hurdle. Peyton also discusses the company’s move into cancer treatments and the announcement that DDDD is expected to make to investors at the end of the first quarter. The CEO also talks about the share price.

 

ig group.PNG

Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...